| Cystic fibrosis–related diabetes: current trends in prevalence, incidence, and mortality A Moran, J Dunitz, B Nathan, A Saeed, B Holme, W Thomas Diabetes care 32 (9), 1626-1631, 2009 | 713 | 2009 |
| Metabolic complications of obesity in childhood and adolescence: more than just diabetes BM Nathan, A Moran Current Opinion in Endocrinology, Diabetes and Obesity 15 (1), 21-29, 2008 | 283 | 2008 |
| The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial AS Kelly, KD Rudser, BM Nathan, CK Fox, AM Metzig, BJ Coombes, ... JAMA pediatrics 167 (4), 355-360, 2013 | 178 | 2013 |
| Obesity in youth with type 1 diabetes in Germany, Austria, and the United States SN DuBose, JM Hermann, WV Tamborlane, RW Beck, A Dost, ... The Journal of pediatrics 167 (3), 627-632. e4, 2015 | 176 | 2015 |
| A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk MJ Redondo, S Geyer, AK Steck, S Sharp, JM Wentworth, MN Weedon, ... Diabetes care 41 (9), 1887-1894, 2018 | 132 | 2018 |
| Intranasal glucagon for treatment of insulin-induced hypoglycemia in adults with type 1 diabetes: a randomized crossover noninferiority study MR Rickels, KJ Ruedy, NC Foster, CA Piché, H Dulude, JL Sherr, ... Diabetes Care 39 (2), 264-270, 2016 | 129 | 2016 |
| Exenatide as a weight‐loss therapy in extreme pediatric obesity: a randomized, controlled pilot study AS Kelly, AM Metzig, KD Rudser, AK Fitch, CK Fox, BM Nathan, ... Obesity 20 (2), 364-370, 2012 | 128 | 2012 |
| Regulation and disorders of pubertal timing BM Nathan, MR Palmert Endocrinology and Metabolism Clinics 34 (3), 617-641, 2005 | 124 | 2005 |
| Glucagon nasal powder: a promising alternative to intramuscular glucagon in youth with type 1 diabetes JL Sherr, KJ Ruedy, NC Foster, CA Piché, H Dulude, MR Rickels, ... Diabetes care 39 (4), 555-562, 2016 | 123 | 2016 |
| Identification and treatment of metabolic complications in pediatric obesity KL Ode, BI Frohnert, BM Nathan Reviews in endocrine and metabolic disorders 10, 167-188, 2009 | 99 | 2009 |
| Endocrine disorders in Fanconi anemia: recommendations for screening and treatment A Petryk, R Kanakatti Shankar, N Giri, AN Hollenberg, MM Rutter, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 803-811, 2015 | 90 | 2015 |
| Metformin improves peripheral insulin sensitivity in youth with type 1 diabetes M Cree-Green, BC Bergman, E Cengiz, LA Fox, TS Hannon, K Miller, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3265-3278, 2019 | 89 | 2019 |
| Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes … MJ Haller, SA Long, JL Blanchfield, DA Schatz, JS Skyler, JP Krischer, ... Diabetes 68 (6), 1267-1276, 2019 | 86 | 2019 |
| Prevalence of cardiovascular risk factors in youth with type 1 diabetes and elevated body mass index MJ Redondo, NC Foster, IM Libman, SN Mehta, JM Hathway, KE Bethin, ... Acta diabetologica 53, 271-277, 2016 | 86 | 2016 |
| Association of osteocalcin with obesity, insulin resistance, and cardiovascular risk factors in young adults LE Polgreen, DR Jacobs Jr, BM Nathan, J Steinberger, A Moran, ... Obesity 20 (11), 2194-2201, 2012 | 73 | 2012 |
| Managing diabetes in cystic fibrosis TA Laguna, BM Nathan, A Moran Diabetes, Obesity and Metabolism 12 (10), 858-864, 2010 | 61 | 2010 |
| Recent trends in cystic fibrosis-related diabetes BM Nathan, T Laguna, A Moran Current Opinion in Endocrinology, Diabetes and obesity 17 (4), 335-341, 2010 | 53 | 2010 |
| A randomized clinical trial assessing continuous glucose monitoring (CGM) use with standardized education with or without a family behavioral intervention compared with … Diabetes Care 44 (2), 464-472, 2021 | 48 | 2021 |
| Meal replacements followed by topiramate for the treatment of adolescent severe obesity: a pilot randomized controlled trial CK Fox, AM Kaizer, KD Rudser, BM Nathan, AC Gross, M Sunni, ... Obesity 24 (12), 2553-2561, 2016 | 45 | 2016 |
| Identical and nonidentical twins: risk and factors involved in development of islet autoimmunity and type 1 diabetes TM Triolo, A Fouts, L Pyle, L Yu, PA Gottlieb, AK Steck Diabetes care 42 (2), 192-199, 2019 | 43 | 2019 |
